B
Beringea
Venture CapitalActiveBeringea is a transatlantic venture capital seeking to create lasting success for rapidly scaling entrepreneurial companies
120
Investments
7
Exits
$750M
AUM
5.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Beringea.
Investment Thesis & Strategy
Beringea is a transatlantic venture capital firm that invests in rapidly scaling entrepreneurial companies across various stages. They focus on building lasting success for their portfolio companies.
Investment Activity
Deals per year over the last 9 years
3
20130
20142
20151
20161
20172
20181
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 120 companies
L
Lume Cannabis Co.
Consumer · Growth, 2021
V
Vera Therapeutics
Biotech · Series B, 2021
B
Bluestem Brands
E-commerce · Growth, 2019
H
Huel
Food & Beverage · Growth, 2018
H
Huron Capital
Other · Growth, 2018
W
Watchfinder
E-commerce · Growth, 2017
N
Nutrabolt
Food & Beverage · Growth, 2016
M
Monica Vinader
Consumer · Growth, 2015
B
Bright.md
Healthcare · Series A, 2015
B
Biohaven Pharmaceutical
Biotech · Series A, 2013
G
Glooko
Healthcare · Series B, 2013
T
The RealReal
E-commerce · Series B, 2013
Notable Exits
CompanyTypeYearValue / Acquirer
Monica VinaderAcquisition2023—
NutraboltIPO2023—
Biohaven PharmaceuticalAcquisition2022$11.6B
Huron CapitalAcquisition2021—
Bluestem BrandsAcquisition2019—
Cengage LearningIPO2013—
ProQuestAcquisition2007—
Frequently Asked Questions
Beringea focuses on Series A, Series B, Series C+ stage investments.